Zongzhen Xu
Jinan, 250014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
circFAM134B is a key factor regulating reticulophagy-mediated ferroptosis in hepatocellular carcinoma.
Journal: Cell cycle (Georgetown, Tex.)
Published: August 21, 2023
Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma.
Journal: Biochemical and biophysical research communications
Published: October 26, 2021
Corrigendum to "RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA" [Exp. Cell Res. 399 (1) (1 February 2021) 112453].
Journal: Experimental cell research
Published: October 02, 2021
RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
Journal: Experimental cell research
Published: July 12, 2020
circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.
Journal: Cell cycle (Georgetown, Tex.)
Published: April 02, 2019
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 15, 2018
Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial-mesenchymal transition.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 06, 2017
P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway.
Journal: Oncology reports
Published: December 29, 2016
Initial study of sediment antagonism and characteristics of silver nanoparticle-coated biliary stents in an experimental animal model.
Journal: International journal of nanomedicine
Published: May 25, 2016
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Journal: Oncology reports
Published: January 11, 2016
Last Updated: 09/26/2026